140 related articles for article (PubMed ID: 23025533)
1. Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
Slager SL; Camp NJ; Conde L; Shanafelt TD; Achenbach SJ; Rabe KG; Kay NE; Novak AJ; Call TG; Bracci PM; Sille FM; Sanchez S; Akers NK; Cunningham JM; Serie DJ; McDonnell SK; Leis JF; Wang AH; Weinberg JB; Glenn M; Link B; Vachon CM; Lanasa MC; Skibola CF; Cerhan JR
Br J Haematol; 2012 Dec; 159(5):572-6. PubMed ID: 23025533
[TBL] [Abstract][Full Text] [Related]
2. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
Slager SL; Achenbach SJ; Asmann YW; Camp NJ; Rabe KG; Goldin LR; Call TG; Shanafelt TD; Kay NE; Cunningham JM; Wang AH; Weinberg JB; Norman AD; Link BK; Leis JF; Vachon CM; Lanasa MC; Caporaso NE; Novak AJ; Cerhan JR
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):461-6. PubMed ID: 23307532
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropy of cancer susceptibility variants on the risk of non-Hodgkin lymphoma: the PAGE consortium.
Lim U; Kocarnik JM; Bush WS; Matise TC; Caberto C; Park SL; Carlson CS; Deelman E; Duggan D; Fesinmeyer M; Haiman CA; Henderson BE; Hindorff LA; Kolonel LN; Peters U; Stram DO; Tiirikainen M; Wilkens LR; Wu C; Kooperberg C; Le Marchand L
PLoS One; 2014; 9(3):e89791. PubMed ID: 24598796
[TBL] [Abstract][Full Text] [Related]
4. Variations in chromosomes 9 and 6p21.3 with risk of non-Hodgkin lymphoma.
Wang SS; Menashe I; Cerhan JR; Cozen W; Severson RK; Davis S; Hutchinson A; Rothman N; Chanock SJ; Bernstein L; Hartge P; Morton LM
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):42-9. PubMed ID: 21148756
[TBL] [Abstract][Full Text] [Related]
5. Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk.
Crowther-Swanepoel D; Mansouri M; Enjuanes A; Vega A; Smedby KE; Ruiz-Ponte C; Jurlander J; Juliusson G; Montserrat E; Catovsky D; Campo E; Carracedo A; Rosenquist R; Houlston RS
Br J Haematol; 2010 Aug; 150(4):473-9. PubMed ID: 20553269
[TBL] [Abstract][Full Text] [Related]
6. Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk.
Crowther-Swanepoel D; Di Bernardo MC; Jamroziak K; Karabon L; Frydecka I; Deaglio S; D'Arena G; Rossi D; Gaidano G; Olver B; Lloyd A; Broderick P; Laurenti L; Szemraj-Rogucka Z; Robak T; Catovsky D; Houlston RS
Br J Haematol; 2011 Jul; 154(2):229-33. PubMed ID: 21554262
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32.
Conde L; Halperin E; Akers NK; Brown KM; Smedby KE; Rothman N; Nieters A; Slager SL; Brooks-Wilson A; Agana L; Riby J; Liu J; Adami HO; Darabi H; Hjalgrim H; Low HQ; Humphreys K; Melbye M; Chang ET; Glimelius B; Cozen W; Davis S; Hartge P; Morton LM; Schenk M; Wang SS; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Becker N; Benavente Y; Boffetta P; Brennan P; Butterbach K; Cocco P; Foretova L; Maynadié M; de Sanjosé S; Staines A; Spinelli JJ; Achenbach SJ; Call TG; Camp NJ; Glenn M; Caporaso NE; Cerhan JR; Cunningham JM; Goldin LR; Hanson CA; Kay NE; Lanasa MC; Leis JF; Marti GE; Rabe KG; Rassenti LZ; Spector LG; Strom SS; Vachon CM; Weinberg JB; Holly EA; Chanock S; Smith MT; Bracci PM; Skibola CF
Nat Genet; 2010 Aug; 42(8):661-4. PubMed ID: 20639881
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.
Slager SL; Rabe KG; Achenbach SJ; Vachon CM; Goldin LR; Strom SS; Lanasa MC; Spector LG; Rassenti LZ; Leis JF; Camp NJ; Glenn M; Kay NE; Cunningham JM; Hanson CA; Marti GE; Weinberg JB; Morrison VA; Link BK; Call TG; Caporaso NE; Cerhan JR
Blood; 2011 Feb; 117(6):1911-6. PubMed ID: 21131588
[TBL] [Abstract][Full Text] [Related]
9. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
[TBL] [Abstract][Full Text] [Related]
10. A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.
Cerhan JR; Fredericksen ZS; Novak AJ; Ansell SM; Kay NE; Liebow M; Dogan A; Cunningham JM; Wang AH; Witzig TE; Habermann TM; Asmann YW; Slager SL
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1799-806. PubMed ID: 22911334
[TBL] [Abstract][Full Text] [Related]
11. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 rearrangements with breakpoints in both vcr and mbr in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.
Merup M; Spasokoukotskaja T; Einhorn S; Smith CI; Gahrton G; Juliusson G
Br J Haematol; 1996 Mar; 92(3):647-52. PubMed ID: 8616030
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.
Blum KA; Liu Z; Lucas DM; Chen P; Xie Z; Baiocchi R; Benson DM; Devine SM; Jones J; Andritsos L; Flynn J; Plass C; Marcucci G; Chan KK; Grever MR; Byrd JC
Br J Haematol; 2010 Jul; 150(2):189-95. PubMed ID: 20456354
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
Law PJ; Sud A; Mitchell JS; Henrion M; Orlando G; Lenive O; Broderick P; Speedy HE; Johnson DC; Kaiser M; Weinhold N; Cooke R; Sunter NJ; Jackson GH; Summerfield G; Harris RJ; Pettitt AR; Allsup DJ; Carmichael J; Bailey JR; Pratt G; Rahman T; Pepper C; Fegan C; von Strandmann EP; Engert A; Försti A; Chen B; Filho MI; Thomsen H; Hoffmann P; Noethen MM; Eisele L; Jöckel KH; Allan JM; Swerdlow AJ; Goldschmidt H; Catovsky D; Morgan GJ; Hemminki K; Houlston RS
Sci Rep; 2017 Jan; 7():41071. PubMed ID: 28112199
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies.
Shen M; Menashe I; Morton LM; Zhang Y; Armstrong B; Wang SS; Lan Q; Hartge P; Purdue MP; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Severson RK; Zahm SH; Chatterjee N; Rothman N; Chanock SJ; Zheng T
Br J Haematol; 2010 Nov; 151(3):239-44. PubMed ID: 20813000
[TBL] [Abstract][Full Text] [Related]
16. Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.
Chen Q; Zheng T; Lan Q; Lerro C; Zhao N; Qin Q; Hu X; Huang H; Liang J; Holford T; Leaderer B; Boyle P; Chanock SJ; Rothman N; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1332-5. PubMed ID: 23640258
[TBL] [Abstract][Full Text] [Related]
17. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
18. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
19. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLymph [correction of IinterLlymph] analysis.
Cocco P; Vermeulen R; Flore V; Nonne T; Campagna M; Purdue M; Blair A; Monnereau A; Orsi L; Clavel J; Becker N; de Sanjosé S; Foretova L; Staines A; Maynadié M; Nieters A; Miligi L; 't Mannetje A; Kricker A; Brennan P; Boffetta P; Lan Q; Rothman N
Occup Environ Med; 2013 Nov; 70(11):795-802. PubMed ID: 23881218
[TBL] [Abstract][Full Text] [Related]
20. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
